ArticleEBioMedicine2020

GATA-4, a potential novel therapeutic target for high-grade meningioma, regulates miR-497, a potential novel circulating biomarker for high-grade meningioma.

Caterina Negroni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.